Assessment of kanashatahwadi kashaya orally alongwith Asnadi Niruha basti in the management of Polycystic ovarian Disease
- Conditions
- Health Condition 1: E889- Metabolic disorder, unspecifiedHealth Condition 2: E889- Metabolic disorder, unspecified
- Registration Number
- CTRI/2023/08/055939
- Lead Sponsor
- Department of Prasuti Tantra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1)Diagnosed with PCOS as defined by Rotterdam criteria.
2)Irregular menses/Scanty menses due to PCOD.
3)Elevated LH and altered ratio of LH:FSH ratio >3
4)Clinical or Biomedical evidence of Hyperandrogenism.
5)Both married and unmarried patients.
1)Diagnosed cases of congenital malformation.
2)Benign and malignant lesion of reproductive organ.
3)Endocrinal dysfunction like Thyroid dysfunction and Adrenal hyperplasia.
4)Patient with Anorectal disease.
5)Patients with HIV/VDRL/HbsAg positive.
6)Patients with Pelvic inflammatory disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the therapeutic efficacy of Oral administration of Kanashatahwadi Kashaya & Asanadi Niruha Basti in 90 days of study period in the management of Polycystic Ovarian Disease <br/ ><br>To explore and understand Ayurvedic theories treatment and practices on Polycystic Ovarian DiseaseTimepoint: 90 days
- Secondary Outcome Measures
Name Time Method In today scenario disorder of menstruation is the commonest amongst all the gyneacological complaints, which have a direct effect on the physical health as well as psychological health & reproductive health of female.Timepoint: 90 days